Ondansetron Injection
Product Images NDC 86211-115

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 86211-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jvet Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton (Carton)
Ondansetron Injection, USP 40 mg/20 mL (2 mg/mL) vial carton label by JVET Pharmaceuticals LLC. The label indicates the product is for intravenous or intramuscular injection, sterile, and a 20 mL multi-dose vial. It includes storage instructions and a list of inactive ingredients. The label prominently features the product name, strength, dosage form, and manufacturer details.*
FDA Label Image

Ondansetron-spl-structure (Ondansetron Spl Structure)

Ondansetron-spl-structure (Ondansetron Spl Structure)
Chemical structure of Ondansetron hydrochloride dihydrate showing its molecular formula with indole, ketone, methyl, and imidazole groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.